Although peripheral CD4+ T cells from NSCLC patients show reduced CCR9 expression compared to healthy controls, post-surgical T cell populations exhibit CCR9 upregulation (42, 43). The gene discussed is CCR9; the disease is non-small cell lung carcinoma.